Table 1.
Characteristic | Regimen | |||
---|---|---|---|---|
| ||||
Interval Secondary Cytoreduction (n = 216) | No Interval Secondary Cytoreduction (n = 208) | |||
|
|
|||
No. of Patients | % | No. of Patients | % | |
Age | ||||
<40 years | 11 | 5.1 | 14 | 6.7 |
40–49 years | 42 | 19.4 | 38 | 18.3 |
50–59 years | 68 | 31.5 | 71 | 34.0 |
60–69 years | 60 | 27.8 | 59 | 28.2 |
≥70 years | 35 | 16.2 | 26 | 12.4 |
| ||||
Race | ||||
Black | 10 | 4.6 | 14 | 6.7 |
White | 198 | 91.7 | 183 | 88.0 |
Hispanic | 5 | 2.3 | 6 | 2.9 |
Other | 3 | 1.4 | 5 | 2.4 |
| ||||
Performance status | ||||
0 | 83 | 38.4 | 83 | 39.7 |
1 | 119 | 55.1 | 108 | 51.9 |
2 | 14 | 6.5 | 17 | 8.1 |
| ||||
Cell type | ||||
Serous adenocarcinoma | 165 | 76.4 | 159 | 76.4 |
Endometrioid adenocarcinoma | 17 | 7.9 | 11 | 5.3 |
Mixed epithelial | 20 | 9.3 | 17 | 8.2 |
Other | 14 | 6.5 | 21 | 10.1 |
| ||||
Measurable disease | 152 | 70.4 | 145 | 69.7 |
| ||||
Stage | ||||
III | 200 | 92.6 | 200 | 96.2 |
IV | 16 | 7.4 | 8 | 3.8 |